BEIJING and CLAREMONT, Calif., Jan. 31 /Xinhua-PRNewswire/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) reports sharply improved volume of bio-fertilizer products during the fourth quarter of 2007. Kiwa Bio-Tech Products (Shandong) Co., Ltd. ("Kiwa Shandong"), the Company's wholly-owned subsidiary operating in the bio-fertilizer industry, sold 114 tons of bio-fertilizer products during the last quarter of 2007 as compared with 14 tons in the same period of 2006, representing over 700% increase.
Mr. Wei Li, the Chief Executive Officer of Kiwa stated: "The newly finished first stage upgrade in Kiwa Shandong has significantly strengthened our capability in manufacturing bio-fertilizer products; and our marketing campaigns during past years raised awareness of Kiwa among customers. Our operation in bio-fertilizer industry is back on track."
At the end of the fourth quarter Kiwa announced that over 900 fertilizer-selling terminals have been established to sell Kiwa fertilizer products. These networks of sales terminals provide excellent direct distribution of Kiwa's Green Food Association approved products.
About Kiwa Bio-Tech Products Group Corporation
The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( http://www.sec.gov ) or visit the Company's website at http://www.kiwabiotech.com .
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.